Abstract
Background: Anxiety and depression are common in cardiac rehabilitation (CR) patients.However, CR programs which incorporate psychological techniques achieve modest reductions in emotional distress. More efficacious interventions that can be easily integrated within services are required. A promising alternative to current psychological interventions is metacognitive therapy (MCT). The aim was to evaluate the acceptability and feasibility of delivering Group-MCT to CR patients experiencing symptoms of anxiety and depression.
Method and Results: Fifty-two CR patients with elevated anxiety and/or depression were recruited to a single-blind randomized feasibility trial across three UK National Health Service Trusts and randomized to usual CR or usual CR plus six weekly sessions of group-MCT. Acceptability and feasibility of adding group-MCT to CR was based on recruitment rates, withdrawal, and drop-out by the primary end-point of 4 months; number of MCT and CR sessions attended; completion of follow-up questionnaires; and ability of the outcome measures to discriminate between patients. The study was also used to re-estimate the required sample size for a full-scale trial. We also examined the extent by which non-specialists adhered to the Group-MCT protocol. Group-MCT was found to be feasible and acceptable for CR patients with anxiety and depression.
Recruitment and retention of participants was high, and attendance rates at CR were similar for both groups.
Conclusion: The results suggest the addition of MCT to CR did not have a negative
impact on retention and support a full-scale trial of Group-MCT for cardiac patients.
Method and Results: Fifty-two CR patients with elevated anxiety and/or depression were recruited to a single-blind randomized feasibility trial across three UK National Health Service Trusts and randomized to usual CR or usual CR plus six weekly sessions of group-MCT. Acceptability and feasibility of adding group-MCT to CR was based on recruitment rates, withdrawal, and drop-out by the primary end-point of 4 months; number of MCT and CR sessions attended; completion of follow-up questionnaires; and ability of the outcome measures to discriminate between patients. The study was also used to re-estimate the required sample size for a full-scale trial. We also examined the extent by which non-specialists adhered to the Group-MCT protocol. Group-MCT was found to be feasible and acceptable for CR patients with anxiety and depression.
Recruitment and retention of participants was high, and attendance rates at CR were similar for both groups.
Conclusion: The results suggest the addition of MCT to CR did not have a negative
impact on retention and support a full-scale trial of Group-MCT for cardiac patients.
| Original language | English |
|---|---|
| Article number | 582 |
| Number of pages | 11 |
| Journal | Frontiers in psychiatry |
| Volume | 11 |
| DOIs | |
| Publication status | Published - 30 Jun 2020 |
Bibliographical note
© 2020 Wells, Reeves, Heal, Fisher, Davies, Heagerty, Doherty andCapobianco.